D
Profound Medical Corp. PRN.TO
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Excellent
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.96
Price History PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -3.98%
30-Day Total Return 10.01%
60-Day Total Return -3.32%
90-Day Total Return -12.94%
Year to Date Total Return -13.47%
1-Year Total Return -11.38%
2-Year Total Return -29.41%
3-Year Total Return -4.90%
5-Year Total Return -31.13%
52-Week High % Change -35.11%
52-Week Low % Change 29.37%
Price PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $15.75
52-Week Low Price $7.90
52-Week Low Price (Date) Feb 11, 2025
52-Week High Price (Date) Jul 29, 2024
Valuation PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 212.03M
Enterprise Value 162.53M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -1.34
Earnings Per Share Growth -3.65%
Price/Earnings To Growth --
Price/Sales (TTM) 27.92
Price/Book (Q) 8.11
Enterprise Value/Revenue (TTM) 18.09
Price $9.89
Enterprise Value/EBITDA (TTM) -5.03
Enterprise Value/EBIT -4.91
Market Cap Category Micro Cap
Dividends and Shares PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 24.54M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 647 476 1350
Address 2400 Skymark Avenue Mississauga, ON L4W 5K5
Website www.profoundmedical.com
Country Canada
Year Founded --
Profitability PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -368.26%
Profit Margin -349.41%
Management Effectiveness PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -44.62%
Return on Equity --
Income Statement PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 1.38M
Total Revenue (TTM) 8.98M
Revenue Per Share $0.37
Gross Profit (TTM) 5.57M
EBITDA (TTM) -32.32M
EBIT (TTM) -33.09M
Net Income (TTM) -31.39M
Net Income Avl. to Common (TTM) -31.39M
Total Revenue Growth (Q YOY) 63.89%
Earnings Growth (Q YOY) -68.30%
EPS Diluted (TTM) -1.34
EPS Diluted Growth (Q YOY) -46.15%
Balance Sheet PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 27.12M
Cash Per Share (Q) $1.11
Total Current Assets (Q) 40.88M
Total Preferred Equity (Q) --
Total Equity (Q) 31.06M
Current Ratio (Q) 6.123
Book Value Per Share (Q) $1.26
Total Assets (Q) 42.24M
Total Current Liabilities (Q) 6.68M
Total Debt (Q) 6.23M
Total Liabilities (Q) 11.17M
Total Common Equity (Q) 31.06M
Cash Flow PRN.TO - TSX Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 18.55M
Net Change in Cash (TTM) -6.50M
Levered Free Cash Flow (TTM) -14.79M
Cash from Operations (TTM) -24.83M
Weiss Ratings